Session Tracks

This track will explore the mechanisms underlying oncogenesis and the role of cancer stem cells in tumor initiation and progression. Emphasis will be placed on novel therapeutic strategies targeting these cells to improve cancer treatment outcomes.

This session will focus on the processes of malignant transformation and the genetic and environmental factors that contribute to mutagenesis. Discussions will include recent findings on how these processes can be targeted for cancer prevention.

This track will highlight the latest advancements in cancer medical research, including innovative methodologies and technologies. Participants will discuss the implications of these advancements for clinical practice and patient outcomes.

This session will delve into the field of molecular oncology, focusing on the application of analytics in understanding cancer biology. Topics will include biomarker discovery and the integration of big data in oncology research.

This track will address the critical issue of cancer health disparities, examining the socio-economic, racial, and geographic factors that influence cancer outcomes. Strategies for reducing these disparities through policy and community engagement will be discussed.

This session will explore innovative approaches to cancer treatment and management, including personalized medicine and combination therapies. The focus will be on improving patient care and enhancing treatment efficacy.

This track will cover best practices in the clinical management of cancer patients, including multidisciplinary approaches to care. Emphasis will be placed on the integration of new treatment modalities into clinical practice.

This session will focus on the latest developments in cancer immunology, including immune checkpoint inhibitors and CAR T-cell therapy. Discussions will highlight the challenges and future directions in harnessing the immune system to combat cancer.

This track will investigate the role of viruses in oncogenesis and the implications for therapeutic interventions. Participants will discuss viral mechanisms of tumorigenesis and potential strategies for viral-targeted therapies.

This session will examine the impact of environmental carcinogens on cancer risk and the strategies for cancer prevention. Emphasis will be placed on public health initiatives and policy implications.

This track will focus on the development of chemical therapeutics and advancements in cancer imaging technologies. Discussions will include the integration of imaging in treatment planning and monitoring therapeutic responses.